GlassScriptPhysician profile
Wilson W Lam
NPI 1427239938
$9,725.05
in general payments reported to CMS, 2019-2025
17 companies · $7,934 in 2025
The $7,934 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2021: $200 · 2022: $127 · 2023: $208 · 2024: $778 · 2025: $7,934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,640 · Food and Beverage: $2,679 · Travel and Lodging: $584 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,640.00 |
| Food and Beverage | $2,678.69 |
| Travel and Lodging | $583.97 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $7,205.55 | 2021-2025 | Optimizer, Optimizer |
| Biosense Webster, INC. | $630.03 | 2022-2025 | Carto 3, Nuvision Ice Catheter |
| Medtronic, INC. | $589.22 | 2024-2025 | Harmony, Micra |
| Medtronic Vascular, INC. | $304.70 | 2019 | |
| W. L. Gore & Associates, INC. | $207.41 | 2024 | Gore Cardioform Septal Occluder |
| Abbott Laboratories | $188.93 | 2019-2022 | |
| Edwards Lifesciences Corporation | $162.53 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Cardiva Medical, INC. | $123.00 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.47 | 2021 | |
| Philips North America LLC | $78.81 | 2022-2024 | (Am5) Lead Management |
| Actelion Pharmaceuticals US, INC. | $33.06 | 2023 | Uptravi, Opsumit |
| Boston Scientific Corporation | $25.49 | 2025 | Farapulse |
| Bayer Healthcare Pharmaceuticals INC. | $20.94 | 2019 | |
| Chiesi USA, INC. | $17.31 | 2021 | |
| Amgen INC. | $17.26 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.34 | 2023 | |
| Bardy Diagnostics, INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilson Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.